GlaxoSmithKline To Acquire 10% Stake In Germany's CureVac, Collaborate On 5 mRNA Vaccines
July 20, 2020 at 07:15 AM EDT
GlaxoSmithKline plc is acquiring a 10% stake in German biopharmaceutical company CureVac, it announced Monday (London time).
